Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Condition:   Alzheimer's Disease Interventions:   Drug: Gantenerumab;   Drug: Placebo Sponsor:   Hoffmann-La Roche Not yet recruiting

Source: ClinicalTrials.gov - February 23, 2018 Category: Research Source Type: clinical trials